Brief: Lifecore Bio Says Co's Audit Committee Concluded FY 22 And FY 21 Statements Should No Longer Be Relied Upon

Lifecore Biomedical

31/10/2023 10:56

Oct 31 (Reuters) - Lifecore Biomedical Inc  LFCR.O :
    * LIFECORE BIOMEDICAL - ON OCT 30, CO'S AUDIT COMMITTEE
CONCLUDED
THAT CO'S FY 22 AND FY 21 STATEMENTS SHOULD NO LONGER BE RELIED
UPON
    * LIFECORE BIOMEDICAL SAYS IDENTIFIES ERRORS IN NON-RELIANCE
PERIODS
    * LIFECORE BIOMEDICAL SAYS IN ADDITION, CO EXPECTS TO
CORRECT
CERTAIN ITEMS THAT PREVIOUSLY IDENTIFIED, CONCLUDED AS
IMMATERIAL FOR NON-RELIANCE PERIODS
    * LIFECORE BIOMEDICAL - INTENDS TO RESTATE FINANCIAL
STATEMENTS
FOR NON-RELIANCE PERIODS TO CORRECT ERRORS IN ANNUAL REPORT ON
FORM 10-K FOR FY 2023

Further company coverage:  LFCR.O 

 ((Reuters.Briefs@thomsonreuters.com;))